
Takara Holdings (TSE:2531) postponed its first quarter results for the fiscal year ending March 2027 after auditors flagged uncertainties in accounting treatment at subsidiary Takara Bio USA Inc., prompting an investigation and a delay beyond the usual disclosure window.
Despite the delayed results, Takara Holdings' share price, at ¥2,168.5, has delivered a strong year to date share price return of 33.86%, while the 1 year total shareholder return of 29.51% sits alongside a three year total shareholder return of 85.43%. This suggests longer term momentum remains intact even as recent events increase perceived governance risk.
Balance the governance risk at Takara Holdings by also reviewing hand-picked companies with stronger financial profiles in our 56 resilient stocks with low risk scores.
Given Takara Holdings' recent share price strength, yet an indicated premium to estimated intrinsic value of about 2%, the market appears cautious about the audit issue. Does that caution align with fundamentals or create a mispricing?
Takara Holdings is currently trading on a P/E of 35.6x, which compares to a peer group average of 57.7x and an Asian beverage industry average of 16.9x. That combination points to a stock that screens cheaper than closer peers, yet carries a clear premium to the broader regional sector.
The P/E ratio compares the share price to earnings per share. For Takara Holdings, it reflects how much investors are paying today for each unit of current earnings from its mix of alcoholic beverages, seasonings, logistics and biotech activities. A higher multiple can signal that the market is willing to pay up for perceived quality of earnings or future profit potential. A lower multiple can point to more cautious expectations.
On Simple Wall St’s checks, Takara Holdings is described as good value against its direct peer average on P/E, yet expensive against the wider Asian beverage industry. That split view matters. The company’s earnings have declined by about 5.1% per year over the past 5 years, with profit margins at 3% compared with 4.5% a year earlier and a Return on Equity of 2.7% that is flagged as low. When earnings are under pressure yet the valuation premium to the broader industry remains in place, it suggests investors may be focusing more on perceived earnings quality, business mix, or non core segments such as Takara Bio Group than on recent profit trends alone.
Compared with the Asian beverage sector’s P/E of 16.9x, Takara Holdings trades on more than double that level. That is a strong gap which implies the market is assigning a much richer multiple than is typical for the region, even as earnings have declined and profit margins narrowed. Against its narrower peer set at 57.7x, however, the current 35.6x multiple looks more conservative, which could signal less aggressive expectations within that closer comparison group.
See what the numbers say about this price — find out in our valuation breakdown.
Result: Price-to-earnings of 35.6x (OVERVALUED)
However, investors still face clear risks. The audit review at Takara Bio USA and Takara Holdings' recent earnings decline could both challenge confidence in the current valuation.
Find out about the key risks to this Takara Holdings narrative.
While the P/E of 35.6x places Takara Holdings somewhere between richer peers and a cheaper wider industry, the SWS DCF model shows a very different picture. With the share price at ¥2,168.5 and an estimated future cash flow value of ¥764.3, the stock screens as overvalued on this method.
That gap suggests investors are paying a high price relative to modeled future cash flows. It also raises a practical question for you: Is the market correctly pricing in qualities that the DCF model does not fully capture, or is this an example where enthusiasm has run ahead of the fundamentals?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Takara Holdings for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 25 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Concerned about how the recent Takara Holdings news should influence your stance today? Review the key numbers, look through the underlying disclosures, and then weigh them against the 2 important warning signs.
If Takara Holdings has caught your attention, do not stop here. Use the Simply Wall St screener to uncover other stocks that might fit your risk and return preferences.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com